ARISe at UMass Chan
ARISe
2 other identifiers
interventional
700
1 country
1
Brief Summary
The goal is to identify the most impactful strategies for capturing attention and enhancing effectiveness of vaccine promotion messages. This will be done using an online survey that employs remote eye-tracking and self report measures to evaluate response to sample vaccine promotion social media content in rural populations in New England. Participants will be randomly assigned into one of 14 conditions in a 2(source: expert vs. influencer) by 7 (themes: constructs from 7C Vaccine Framework) experiment and view sample messages and then answer questions about their attitudes and beliefs while being monitored for eye-tracking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 1, 2025
CompletedFirst Posted
Study publicly available on registry
November 19, 2025
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
December 22, 2025
December 1, 2025
6 months
October 1, 2025
December 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Source credibility
Participants' perception of the credibility of the message source will be assessed using a 7-point Likert scale measured across four items. Participants will be asked to rate the following four items on this scale: To what extent do you believe the source of the message to be… (1=not at all, 7=very much so) 1. Fair 2. Accurate 3. Telling the whole story 4. Trustworthy Unit of measure: Scale score 1-7, mean
Immediately after viewing each message
Perceived Message Effectiveness
Perceived message effectiveness will be measured using six items (worth remembering, grabs attention, powerful, informative, meaningful, convincing), each rated on a 7-point Likert scale. The outcome will be the mean of these six ratings for each participant, then averaged by experimental condition. To what extent is… (1=not at all, 7=very much so) 1. The message worth remembering 2. The message grabs attention 3. This message powerful 4. This message informative 5. This message meaningful 6. This message convincing Unit of Measure: Scale score (1-7, mean across items)
Immediately after viewing each message
Visual attention
Visual attention, quantified as mean dwell time in milliseconds, will be measured using remote eye-tracking while participants view vaccine promotion messages. Dwell time will be calculated for pre-specified Areas of Interest (AOIs) during the message viewing period. Higher dwell times indicate greater visual attention to the AOIs. Unit of measure: mean dwell time in milliseconds per message
During message viewing ( immediately post-randomization, prior to completion of post-message survey)
Message reactance
Reactance will be assessed using four items (irritated, angry, annoyed, aggravated), rated 0 ("None of this feeling") to 4 ("A great deal of this feeling"). The mean reactance score will be calculated for each participant. How much did this message make you feel the following way? Response options: 0 (None of this feeling) to 4 (A great deal of this feeling). 1. Irritated 2. Angry 3. Annoyed 4. Aggravated Unit of Measure: Scale score (0-4, mean across items)
Immediately after viewing each message
Information sharing intentions
Description: Assessed with 6 items regarding interpersonal and online sharing, rated 1 (Strongly disagree) to 5 (Strongly agree). The mean score across items will be reported per participant and per condition. Rate with the following statements on a scale from 1 (Strongly disagree) to 5 (Strongly agree). Interpersonal setting 1. I would be willing to share this information with others. 2. I would talk with others about this message. 3. I would point others in a direction where they could read this message. Online setting 4. I would be willing to post a link to this information on my social media. 5. I would like a social media post with this information. 6. I would share a social media post with this information. Unit of Measure: Scale score (1-5, mean across items)
Immediately after viewing each message
Secondary Outcomes (1)
Vaccine perceptions
Assessed at baseline (prior to message exposure) and immediately post-intervention (after message exposure)
Study Arms (14)
Arm 1: Peer message, 7C Construct 1
EXPERIMENTALThis arm will include messages with a "peer" influence as the source and the construct of "confidence" as the message.
Arm 2: Professional source, 7C Construct 1
EXPERIMENTALThis arm will include messages with a "professional" influencer as the source and the construct of "confidence" as the message.
Arm 3: Peer message, 7C Construct 2
EXPERIMENTALThis arm will include messages with a "peer" influence as the source and the construct of "complacency" as the message.
Arm 4: Professional message, 7C Construct 2
EXPERIMENTALThis arm will include messages with a "professional" influence as the source and the construct of "complacency" as the message.
Arm 5: Peer message, 7C Construct 3
EXPERIMENTALThis arm will include messages with a "peer" influence as the source and the construct of "constraints" as the message.
Arm 6: Professional message, 7C Construct 3
EXPERIMENTALThis arm will include messages with a "professional" influencer as the source and the construct of "constraints" as the message.
Arm 7: Peer message, 7C Construct 4
EXPERIMENTALThis arm will include messages with a "peer" influencer as the source and the construct of "calculation" as the message.
Arm 8: Professional message, 7C Construct 4
EXPERIMENTALThis arm will include messages with a "professional" influencer as the source and the construct of "calculation" as the message.
Arm 9: Peer message, 7C Construct 5
EXPERIMENTALThis arm will include messages with a "peer" influencer as the source and the construct of "collective responsibility" as the message.
Arm 10: Professional message, 7C Construct 5
EXPERIMENTALThis arm will include messages with a "professional" influencer as the source and the construct of "collective responsibility" as the message.
Arm 11: Peer message; 7C Construct 6
EXPERIMENTALThis arm will include messages with a "peer" influencer as the source and the construct of "compliance" as the message.
Arm 12: Professional message, 7C Construct 6
EXPERIMENTALThis arm will include messages with a "professional" influencer as the source and the construct of "compliance" as the message.
Arm 13: Peer message, 7C Construct 7
EXPERIMENTALThis arm will include messages with a "peer" influencer as the source and the construct of "conspiracy" as the message.
Arm 14: Professional message, 7C Construct 7
EXPERIMENTALThis arm will include messages with a "professional" influencer as the source and the construct of "conspiracy" as the message.
Interventions
Within each arm, participants will be exposed to two messages each of which are delivered by the same source (peer or professional) and have message content related to one of the 7C Constructs.
Eligibility Criteria
You may qualify if:
- Age 18+
- Living in New England state (CT, MA, ME, NH, VT RI) in a zip code as defined by each individual state's definition of rural
- Able to read and write in English
- Access to an internet connected computer or laptop with a web-camera
You may not qualify if:
- N/A
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Massachusetts Chan Medical School
Worcester, Massachusetts, 01605, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Grace W Ryan, PhD, MPH
University of Massachusetts Chan Medical School
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 1, 2025
First Posted
November 19, 2025
Study Start
December 1, 2025
Primary Completion (Estimated)
May 30, 2026
Study Completion (Estimated)
September 30, 2026
Last Updated
December 22, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
Per the data management plan, datasets and codebooks will be provided to individual researchers upon reasonable request.